发明名称 |
HCV RNA REPLICATION INHIBITOR |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide the use of a compound useful as a human hepatitis C virus RNA replication inhibitor or a therapeutic agent for human hepatitis C virus infectious diseases and a method of screening the compound. <P>SOLUTION: N-acetylglucosamine acts to inhibit the RNA replication of human hepatitis C virus and accordingly, is useful as a human hepatitis C virus RNA replication inhibitor, a therapeutic agent for human hepatitis C virus infectious disease or the like, and the use of an N-acetylglucosamine derivative using N-acetylglucosamine as a lead compound enables screening of the human hepatitis C virus RNA replication inhibitor and the human hepatitis C virus infectious disease therapeutic agent. <P>COPYRIGHT: (C)2012,JPO&INPIT |
申请公布号 |
JP2012171870(A) |
申请公布日期 |
2012.09.10 |
申请号 |
JP20110032399 |
申请日期 |
2011.02.17 |
申请人 |
KEIO GIJUKU;HAMAMATSU UNIV SCHOOL OF MEDICINE;YAIZU SUISANKAGAKU INDUSTRY CO LTD |
发明人 |
SATO TOMONORI;SUZUKI TETSURO;KAWAGUCHI MITSUAKI |
分类号 |
A61K31/7008;A61P1/16;A61P31/14;C07H5/06;C12Q1/02;C12Q1/68;G01N33/15;G01N33/50 |
主分类号 |
A61K31/7008 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|